Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - CASCADE MICROTECH INC | d812549d8k.htm |
Exhibit 99.1
Cascade Microtech Reports Third Quarter 2014 Results
Revenue of $33.5 million
Record Gross Margin of 52.3%
Record Income from Operations of $3.6 million
Record Adjusted EBITDAS of $5.5 million
GAAP EPS of $0.13
Non-GAAP EPS of $0.15
BEAVERTON, Ore.—(MARKETWIRE) — October 28, 2014 —Cascade Microtech, Inc. (NASDAQ:CSCD) today reported financial results for the third quarter ended September 30, 2014.
Financial Summary
Results for the quarter ended September 30, 2014 were as follows:
| • | Total revenue of $33.5 million, compared to $33.5 million for Q2 2014 and $28.2 million for Q3 2013. |
| – | Systems revenue of $19.4 million, a decrease of $2.4 million, or 11.1%, from Q2 2014, and an increase of $1.9 million, or 10.9%, over Q3 2013. |
| – | Probes revenue of $14.1 million, an increase of $2.4 million, or 20.9%, from Q2 2014, and an increase of $3.4 million, or 31.5%, over Q3 2013. |
| – | Q3 2014 set a new revenue record for our Probes segment. |
| • | Gross margin of 52.3%, up from 50.8% in Q2 2014 and 47.6% in Q3 2013. |
| – | Systems gross margin of 42.0%, down from 46.5% in Q2 2014 and 42.7% in Q3 2013. |
| – | Probes gross margin of 66.5%, up from 58.9% in Q2 2014 and 55.6% in Q3 2013. |
| – | Q3 2014 represents record gross margin performance for our Probes segment and overall business. |
| • | Income from operations of $3.6 million, an increase of $0.7 million, or 23.4%, over Q2 2014, and an increase of $2.0 million, or 130.0%, over Q3 2013. |
| – | Q3 2014 set a new record for operating profitability. |
| • | GAAP net income of $2.2 million, or $0.13 per diluted share, compared to $1.8 million, or $0.11 per diluted share, for Q2 2014, and $1.7 million, or $0.11 per diluted share, for Q3 2013. |
| • | Non-GAAP net income of $0.15 per diluted share, compared to $0.13 per diluted share for Q2 2014, and $0.16 per diluted share for Q3 2013. |
| • | Depreciation, amortization and stock-based compensation expenses totaled $2.2 million, compared to $2.4 million for Q2 2014 and $1.5 million for Q3 2013. |
| • | Adjusted EBITDAS of $5.5 million, compared to $5.1 million for Q2 2014 and $3.7 million for Q3 2013. |
| – | Q3 2014 set a new record for adjusted EBITDAS. |
| • | Total cash and investments of $31.4 million, an increase of $1.1 million over quarter Q2 2014. |
| • | Book-to-bill ratio of 1.14 to 1. |
“The third quarter of 2014 set a number of new records for Cascade Microtech, including gross margins, income from operations, adjusted EBITDAS, and Probes revenue, which grew sequentially over 20%. These records reflect our ongoing progress towards achieving our Success Model. All of our product lines posted book-to-bill ratios greater than one, which positions us for a strong fourth quarter,” said Michael Burger, President and CEO.
Financial Outlook
For the fourth quarter of 2014 we are projecting revenue in the range of $35.0 million to $38.0 million, with diluted GAAP earnings per share in the range of $0.12 to $0.18, and non-GAAP earnings per share in the range of $0.15 to $0.21. Our guidance assumes a tax rate of 36%, consistent foreign currency exchange rates and no significant one-time charges.
We will host a conference call beginning at 5:00 p.m. EDT (2:00 p.m. PDT) on Tuesday October 28, 2014, to discuss our results for the quarter ended September 30, 2014.
1
A simultaneous audio cast of the conference call may be accessed online from the investor relations page of www.cascademicrotech.com/investors. If you are interested in participating in the call, the live dial-in number is 877-415-3186, or international 857-244-7329, participant Passcode: 60945388. A replay will be available after 10:00 p.m. EDT at the same internet address. (For a telephone replay available after 10:00 p.m. EDT, dial: 888-286-8010, international: 617-801-6888, Passcode: 43467652).
Forward-Looking Statements
The statements in this release regarding progress towards the Success Model, our expectations relating to the fourth quarter of 2014, and statements under “Financial Outlook” regarding projected revenue, GAAP earnings per share, and non-GAAP earnings per share, and other statements identified by terminology such as “will,” “should,” “expects,” “estimates,” “predicts,” and “continue” or other derivations of these or other comparable terms are “forward-looking” statements within the meaning of the Securities Litigation Reform act of 1995. Such statements are based on current expectations, estimates and projections about the Company’s business based in part on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including: changes in demand for the Company’s products; changes in product mix; potential delays and other factors affecting the timing of new product introductions; the timing of shipments and customer orders; constraints on supplies of components; excess or shortage of production capacity; potential failure of expected market opportunities to materialize; changes in foreign exchange rates; our ability or delay in integrating acquired businesses; and other risks discussed from time to time in the Company’s Securities and Exchange Commission filings and reports, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. In addition, such statements could be affected by general industry and market conditions and growth rates and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release.
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance with U.S. generally accepted accounting principles (GAAP), the Company’s earnings release contains Non-GAAP financial measures, which are defined below and reconciled to GAAP financial measures in a table later in this release:
| • | Non-GAAP net income is defined as GAAP net income before certain items (adjustments) such as restructuring, facility move and project costs, acquisition-related expenses, the amortization of intangibles and discrete tax items that we believe are either not representative of our ongoing operating performance or effect the comparability of results over time. Non-GAAP net income should not be construed as a substitute for net income as defined by GAAP. However, we regard non-GAAP net income as a complement to GAAP net income in assessing our financial performance over time and in the future. |
| • | Adjusted EBITDAS is defined as income from continuing operations before depreciation and amortization and stock-based compensation and certain other items (adjustments) such as restructuring, facility move and project costs, and acquisition-related expenses that we believe are not representative of our ongoing operating performance. Adjusted EBITDAS should not be construed as a substitute for net income from continuing operations or net cash provided by (used in) operating activities (all as determined in accordance with GAAP) for the purpose of analyzing our operating performance, financial position and cash flows, as adjusted EBITDAS is not defined by GAAP. However, we regard adjusted EBITDAS as a complement to net income from continuing operations and other GAAP financial performance measures, by including an indirect measure of operating cash flow. |
About Cascade Microtech, Inc.
Cascade Microtech, Inc. (NASDAQ: CSCD) is a worldwide leader in precision contact, electrical measurement and test of integrated circuits (ICs), optical devices and other small structures. For technology businesses and scientific institutions that need to evaluate small structures, Cascade Microtech delivers access to electrical data from wafers, ICs, IC packages, circuit boards and modules, MEMS, 3D TSV, LED devices and more. Cascade Microtech’s leading-edge stations, probes, probe cards, advanced thermal subsystems and integrated systems deliver precision accuracy and superior performance both in the lab and during production manufacturing of high-speed and high-density semiconductor chips. For more information, visit www.cascademicrotech.com.
2
FOR MORE INFORMATION, CONTACT:
Jeff A. Killian
Cascade Microtech, Inc.
(503) 601-1280
###
3
CASCADE MICROTECH, INC.
AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)
| Three Months Ended | ||||||||||||||||||||
| September 30, | June 30, | September 30, | Nine Months Ended September 30, | |||||||||||||||||
| 2014 | 2014 | 2013 | 2014 | 2013 | ||||||||||||||||
| Revenue |
$ | 33,473 | $ | 33,452 | $ | 28,197 | $ | 100,735 | $ | 85,975 | ||||||||||
| Cost of sales |
15,953 | 16,466 | 14,779 | 49,956 | 46,739 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Gross profit |
17,520 | 16,986 | 13,418 | 50,779 | 39,236 | |||||||||||||||
| Operating expenses: |
||||||||||||||||||||
| Research and development |
3,554 | 3,428 | 2,750 | 10,223 | 7,900 | |||||||||||||||
| Selling, general and administrative |
10,352 | 10,630 | 9,097 | 31,412 | 26,207 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| 13,906 | 14,058 | 11,847 | 41,635 | 34,107 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Income from operations |
3,614 | 2,928 | 1,571 | 9,144 | 5,129 | |||||||||||||||
| Other income (expense): |
||||||||||||||||||||
| Interest income, net |
16 | 7 | 18 | 25 | 40 | |||||||||||||||
| Other, net |
(235 | ) | (56 | ) | 87 | (360 | ) | (269 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (219 | ) | (49 | ) | 105 | (335 | ) | (229 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Income before income taxes |
3,395 | 2,879 | 1,676 | 8,809 | 4,900 | |||||||||||||||
| Income tax expense (benefit) |
1,188 | 1,051 | (7 | ) | 3,182 | 284 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ | 2,207 | $ | 1,828 | $ | 1,683 | $ | 5,627 | $ | 4,616 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income per share: |
||||||||||||||||||||
| Basic |
$ | 0.13 | $ | 0.11 | $ | 0.12 | $ | 0.35 | $ | 0.32 | ||||||||||
| Diluted |
$ | 0.13 | $ | 0.11 | $ | 0.11 | $ | 0.34 | $ | 0.31 | ||||||||||
| Shares used in computing net income per share: |
||||||||||||||||||||
| Basic |
16,357 | 16,255 | 14,453 | 16,286 | 14,339 | |||||||||||||||
| Diluted |
16,851 | 16,751 | 14,797 | 16,775 | 14,688 | |||||||||||||||
4
CASCADE MICROTECH, INC.
AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
| September 30, | December 31, | |||||||
| 2014 | 2013 | |||||||
| Assets | ||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 29,717 | $ | 17,172 | ||||
| Marketable securities |
1,703 | 4,278 | ||||||
| Restricted cash |
— | 1,082 | ||||||
| Accounts receivable, net |
22,332 | 26,520 | ||||||
| Inventories |
26,215 | 24,884 | ||||||
| Deferred income taxes |
2,262 | 2,268 | ||||||
| Prepaid expenses and other |
4,961 | 2,147 | ||||||
|
|
|
|
|
|||||
| Total current assets |
87,190 | 78,351 | ||||||
| Fixed assets, net |
7,537 | 6,403 | ||||||
| Goodwill |
13,309 | 14,471 | ||||||
| Purchased intangible assets, net |
13,658 | 16,937 | ||||||
| Deferred income taxes |
1,553 | 1,235 | ||||||
| Other assets |
1,191 | 1,114 | ||||||
|
|
|
|
|
|||||
| $ | 124,438 | $ | 118,511 | |||||
|
|
|
|
|
|||||
| Liabilities and Shareholders’ Equity | ||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 7,259 | $ | 7,229 | ||||
| Deferred revenue |
2,316 | 2,555 | ||||||
| Accrued liabilities |
10,279 | 8,859 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
19,854 | 18,643 | ||||||
| Deferred revenue |
309 | 548 | ||||||
| Other long-term liabilities |
1,845 | 2,119 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
22,008 | 21,310 | ||||||
| Shareholders’ equity: |
||||||||
| Common stock |
109,813 | 108,070 | ||||||
| Accumulated other comprehensive income (loss) |
(2,023 | ) | 118 | |||||
| Accumulated deficit |
(5,360 | ) | (10,987 | ) | ||||
|
|
|
|
|
|||||
| Total shareholders’ equity |
102,430 | 97,201 | ||||||
|
|
|
|
|
|||||
| $ | 124,438 | $ | 118,511 | |||||
|
|
|
|
|
|||||
5
CASCADE MICROTECH, INC.
AND SUBSIDIARIES
Reconciliation of GAAP to Non-GAAP Financial Measures
(in thousands, except per share amounts)
(unaudited)
| Three Months Ended | ||||||||||||||||||||
| September 30, | June 30, | September 30, | Nine Months Ended September 30, | |||||||||||||||||
| 2014 | 2014 | 2013 | 2014 | 2013 | ||||||||||||||||
| Non-GAAP Net Income |
||||||||||||||||||||
| GAAP net income |
$ | 2,207 | $ | 1,828 | $ | 1,683 | $ | 5,627 | $ | 4,616 | ||||||||||
| Adjustments to net income: |
||||||||||||||||||||
| Restructuring |
(191 | ) | 249 | — | 58 | 112 | ||||||||||||||
| Acquisition and acquisition related |
(100 | ) | (457 | ) | 627 | (557 | ) | 627 | ||||||||||||
| Amortization of intangibles |
752 | 780 | 264 | 2,317 | 735 | |||||||||||||||
| Income tax effect of non-GAAP adjustments |
(161 | ) | (209 | ) | (64 | ) | (661 | ) | (117 | ) | ||||||||||
| Discrete tax items |
— | — | (127 | ) | — | (127 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-GAAP net income |
$ | 2,507 | $ | 2,191 | $ | 2,383 | $ | 6,784 | $ | 5,846 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| GAAP net income per diluted share |
$ | 0.13 | $ | 0.11 | $ | 0.11 | $ | 0.34 | $ | 0.31 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-GAAP net income per diluted share |
$ | 0.15 | $ | 0.13 | $ | 0.16 | $ | 0.40 | $ | 0.40 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Shares used in diluted share calculations |
16,851 | 16,751 | 14,797 | 16,775 | 14,688 | |||||||||||||||
| Three Months Ended | ||||||||||||||||||||
| September 30, | June 30, | September 30, | Nine Months Ended September 30, | |||||||||||||||||
| 2014 | 2014 | 2013 | 2014 | 2013 | ||||||||||||||||
| EBITDAS and Adjusted EBITDAS |
||||||||||||||||||||
| GAAP Income from operations |
$ | 3,614 | $ | 2,928 | $ | 1,571 | $ | 9,144 | $ | 5,129 | ||||||||||
| Adjustments: |
||||||||||||||||||||
| Depreciation |
824 | 799 | 882 | 2,452 | 2,787 | |||||||||||||||
| Amortization of intangibles |
752 | 780 | 264 | 2,317 | 735 | |||||||||||||||
| Stock-based compensation |
648 | 821 | 343 | 1,918 | 1,215 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| EBITDAS |
5,838 | 5,328 | 3,060 | 15,831 | 9,866 | |||||||||||||||
| Adjustments: |
||||||||||||||||||||
| Restructuring |
(191 | ) | 249 | — | 58 | 112 | ||||||||||||||
| Acquisition and acquisition related |
(100 | ) | (457 | ) | 627 | (557 | ) | 627 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Adjusted EBITDAS |
$ | 5,547 | $ | 5,120 | $ | 3,687 | $ | 15,332 | $ | 10,605 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Three Months Ending December 31, 2014 | ||||||||
| Low Range Guidance | High Range Guidance | |||||||
| Forward-looking non-GAAP net income |
||||||||
| GAAP net income |
$ | 2,000 | $ | 3,000 | ||||
| Adjustments: |
||||||||
| Amortization of intangibles |
752 | 752 | ||||||
| Income tax effect of non-GAAP adjustments |
(269 | ) | (269 | ) | ||||
|
|
|
|
|
|||||
| Non-GAAP net income |
$ | 2,483 | $ | 3,483 | ||||
|
|
|
|
|
|||||
| GAAP net income per diluted share |
$ | 0.12 | $ | 0.18 | ||||
|
|
|
|
|
|||||
| Non-GAAP net income per diluted share |
$ | 0.15 | $ | 0.21 | ||||
|
|
|
|
|
|||||
| Shares used in diluted share calculations |
16,950 | 16,950 | ||||||
6